SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-21-000038
Filing Date
2021-06-16
Accepted
2021-06-16 17:06:59
Documents
13
Period of Report
2021-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim-20210615x8k.htm   iXBRL 8-K 114104
2 EX-10.1 alim-20210615xex10_1.htm EX-10.1 331441
  Complete submission text file 0001267602-21-000038.txt   608711

Data Files

Seq Description Document Type Size
3 EX-101.SCH alim-20210615.xsd EX-101.SCH 2217
4 EX-101.LAB alim-20210615_lab.xml EX-101.LAB 18505
5 EX-101.PRE alim-20210615_pre.xml EX-101.PRE 11438
6 EXTRACTED XBRL INSTANCE DOCUMENT alim-20210615x8k_htm.xml XML 4824
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 211022240
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences